Zobrazeno 1 - 10
of 79
pro vyhledávání: '"N. van der Vange"'
Publikováno v:
Tjiong, M Y, Out, T A, Ter Schegget, J, Burger, M P M & Van Der Vange, N 2001, ' Epidemiologic and mucosal immunologic aspects of HPV infection and HPV-related cervical neoplasia in the lower female genital tract : A review ', International Journal of Gynecological Cancer, vol. 11, no. 1, pp. 9-17 . https://doi.org/10.1046/j.1525-1438.2001.011001009.x
Human papillomavirus (HPV) infections are known to play an important role in the pathogenesis of cervical neoplasia. Considering the morbidity and mortality of cervical cancer, infection with HPV can be regarded as a worldwide problem, especially in
Autor:
L. Struyk, Ming Y. Tjiong, N. van der Vange, Theo A. Out, Klaus Zumbach, Michael Pawlita, J. Ter Schegget
Publikováno v:
Tjiong, M Y, Zumbach, K, Ter Schegget, J, Van Der Vange, N, Out, T A, Pawlita, M & Struyk, L 2001, ' Antibodies against human papillomavirus type 16 and 18 E6 and E7 proteins in cervicovaginal washings and serum of patients with cervical neoplasia ', Viral immunology, vol. 14, no. 4, pp. 415-424 . https://doi.org/10.1089/08828240152716655
Viral immunology, 14(4), 415-424. Mary Ann Liebert Inc.
Viral immunology, 14(4), 415-424. Mary Ann Liebert Inc.
Serum antibodies against the E6 and E7 proteins of human papillomavirus (HPV) 16 and 18 are associated with cervical cancer. The aim of this study was to investigate the presence of local antibodies against HPV in cervicovaginal washings (CWs). In th
Autor:
P.J.M. van de Vaart, M. M. Kaag, A.R. van Goethem, W.W. ten Bokkel Huinink, J. H. Beijnen, F.A.N. Zoetmulder, N. van der Vange
Publikováno v:
European Journal of Surgical Oncology. 26:663-668
Aims: The feasibility, morbidity and toxicity of an intensified surgical treatment strategy consisting of aggressive cytoreductive surgery, intra-operative intraperitoneal perfusion of cisplatin and hyperthermia were evaluated in women with recurrent
Autor:
Theo A. Out, S. P. Tjiong-A-Hung, Matthé P.M. Burger, J. Ter Schegget, Linda Struyk, Ming Y. Tjiong, N. van der Vange
Publikováno v:
International Journal of Gynecological Cancer, 10(4), 296-304. Wolters Kluwer Health
Tjiong, M Y, Ter Schegget, J, Tjiong-A-Hung, S P, Out, T A, Van Der Vange, N, Burger, M P M & Struyk, L 2000, ' IgG antibodies against human papillomavirus type 16 E7 proteins in cervicovaginal washing fluid from patients with cervical neoplasia ', International Journal of Gynecological Cancer, vol. 10, no. 4, pp. 296-304 . https://doi.org/10.1046/j.1525-1438.2000.010004296.x
International journal of gynecological cancer, 10(4), 296-304. Wolters Kluwer Health
Tjiong, M Y, Ter Schegget, J, Tjiong-A-Hung, S P, Out, T A, Van Der Vange, N, Burger, M P M & Struyk, L 2000, ' IgG antibodies against human papillomavirus type 16 E7 proteins in cervicovaginal washing fluid from patients with cervical neoplasia ', International Journal of Gynecological Cancer, vol. 10, no. 4, pp. 296-304 . https://doi.org/10.1046/j.1525-1438.2000.010004296.x
International journal of gynecological cancer, 10(4), 296-304. Wolters Kluwer Health
Little information is available about the cervicovaginal mucosal antibodies against human papillomavirus (HPV) proteins. In this study specific IgG antibodies against HPV 16 E7 protein were determined in paired samples of cervicovaginal washing fluid
Autor:
P.J.F. (Peter) Snijders, J. W. van Oostveen, J.M.M Walboomers, T. D. De Gruijl, C.J.L.M. (Chris) Meijer, R.H.M. Verheijen, A.J.C. van den Muysenberg, R.J Scheper, M.J Stukart, H.J Bontkes, N. van der Vange
Publikováno v:
European Journal of Cancer, 35(3), 490-497. Pergamon
De Gruijl, T D, Bontkes, H J, Van den Muysenberg, A J C, Van Oostveen, J W, Stukart, M J, Verheijen, R H M, Van der Vange, N, Snijders, P J F, Meijer, C J L M, Walboomers, J M M & Scheper, R J 1999, ' Differences in cytokine mRNA profiles between premalignant and malignant lesions of the uterine cervix ', European Journal of Cancer, vol. 35, no. 3, pp. 490-497 . https://doi.org/10.1016/S0959-8049(98)00371-2
De Gruijl, T D, Bontkes, H J, Van den Muysenberg, A J C, Van Oostveen, J W, Stukart, M J, Verheijen, R H M, Van der Vange, N, Snijders, P J F, Meijer, C J L M, Walboomers, J M M & Scheper, R J 1999, ' Differences in cytokine mRNA profiles between premalignant and malignant lesions of the uterine cervix ', European Journal of Cancer, vol. 35, no. 3, pp. 490-497 . https://doi.org/10.1016/S0959-8049(98)00371-2
The aim of this study was to assess the expression of cytokine transcripts, reflecting the type of ongoing immune responses at the site of human papillomavirus (HPV) infection, in relation to the development of cervical neoplasia. To this end reverse
Autor:
O. van Tellingen, A.R. van Goethem, W.W. ten Bokkel Huinink, F.A.N Zoetmulder, Adrian C. Begg, Jos H. Beijnen, P.J.M. van de Vaart, Harry Bartelink, N. van der Vange
Publikováno v:
European Journal of Cancer. 34:148-154
The purpose of this study was to investigate the influence of hyperthermia on cisplatin pharmacokinetics and DNA adduct formation. The latter was investigated both in tumour cell lines in vitro and in tumour cells and buccal cells from cancer patient
Autor:
F. J.W. Ten Kate, N. van der Vange, M. Van Beurden, S. P. Tjong-A-Hung, J. Ter Schegget, F. B. Lammes, A. J. M. De Craen
Publikováno v:
International journal of gynecological pathology, 17(1), 12-16. Lippincott Williams and Wilkins
Human papillomavirus (HPV) DNA in vulvar intraepithelial neoplasia (VIN) is associated with multifocality of VIN III and with multicentricity of other neoplastic squamous lesions in the cervix and vagina. The aim of this study was to establish the pr
Publikováno v:
Anticancer research. 23(2B)
HIPEC is a new treatment modality for abdominal cancers that combines cytoreductive surgery with Hyperthermic, Intraoperative Peritoneal Chemotherapy, followed by systemic chemotherapy. A significant survival benefit has been shown for HIPEC compared
Publikováno v:
Photochemistry and photobiology. 74(2)
The in vivo pharmacokinetics of protoporphyrin IX (PpIX) after administration of 5-aminolevulinic acid (ALA) cannot be described accurately by mathematical models using first-order rate processes. We have replaced first-order reaction rates by dose-d
Autor:
R Rosso, Aj. Lacave, F. Duffaud, K. J. Roozendaal, Jp. Guastalla, Nina Einhorn, Salvatore Tumolo, N. van der Vange, Pierre Kerbrat, Martine Piccart, M Namer, Wt. Huinink, Phb Willemse, M. Nooij, Mel Van der Burg, Jb. Vermorken, Taw. Splinter, Jaques Wils, G. Favalli, Ignace Vergote
Publikováno v:
Anti-Cancer Drugs, 12(2), 159-162. LIPPINCOTT WILLIAMS & WILKINS
Anticancer drugs
Anticancer drugs
Between March and September 1988, 74 patients with progressive ovarian cancer after prior platinum-based therapy were treated with the luteinizing hormone-releasing hormone (LHRH) agonist Triptorelin (Decapeptyl(R)). Treatment consisted of i.m. injec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfa20b346a5f014eef5980a7b5eaef24
https://research.rug.nl/en/publications/ea03d583-e3d9-4091-92f1-adf4724f9d62
https://research.rug.nl/en/publications/ea03d583-e3d9-4091-92f1-adf4724f9d62